J4 ›› 2014, Vol. 13 ›› Issue (2): 47-51.

Previous Articles     Next Articles

Application of 23-gauge Micro-invasive Vitrectomy for Vitreoretinopathy Disease

  

  1. Dali Affiliated Hospital of Dali University, Dali, Yunnan 671000, China
  • Received:2013-11-04 Online:2014-02-15 Published:2014-02-15

Abstract:

Objective: To investigate the application of 23-gauge transconjunctival sutureless vitrectomy system(23-GTVS)in the
treatment of vitreoretinopathy disease and evaluate the efficacy,safety and complications. Methods: A 48 cases of 23-GTVS in our hospital from October 2011 to October 2013 was conducted retrospective analysis,including 8 eyes of idiopathic macular hole(16.7%), 5 eyes of idiopathic macular epiretinal membrane(10.4%),19 eyes of vitreous hemorrhage(29.5%), 8 eyes of peripheral diabetic retinopathy(PDR stage V-VI)(16.7%)and8 eyes of rhegmatogenous retinal detachment(RRD)(16.7%).Intraocular pressure preoperative as well as 1 day,7 days and 1 month postoperative, surgical effects, surgical time, best corrected visual acuity and complications were observed both in suture group and non-suture group. The follow-up time was from 1 month to 12 months. Results:
All cases were successfully completed operation and there were no statistical differences in intraocular pressure of different time points between two group(P>0.05). Best corrected visual acuities postoperative both improved in two groups(P<0.01). The mean surgery time was 70.12±7.86 min and there was few complication found. The intraoperative complications included 2 cases of slippage of intubation tube in,5 cases of slight hemorrhage under conjunctiva and 3 cases of bubble under conjunctiva.No serious postoperative complication was observed during the follow-up time in all cases. Conclusion: 23-GTVS, showing shorter operative-time,faster postoperative recovery,better curative effect and rare complications, was an effective and safe surgical technique in the management of vitreoretinopathy disease.

Key words: 23-gauge, micro-invasive, vitrectomy, vitreoretinopathy

CLC Number: